Drug Pipeline

Itacitinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05757219 Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy Diffuse Large B Cell Lymphoma Recruiting
NCT04859946 Itacitinib for the Prevention of Graft Versus Host Disease Hematologic and Lymphocytic Disorder Active, Not Recruiting
NCT05364762 Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus… Acute Lymphoblastic Leukemia Active, Not Recruiting
Phase 1/2
NCT04061421 Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap… MDS/MPN Recruiting
Sponsors Running Itacitinib Trials
Michael Savona (1) M.D. Anderson Cancer Center (1) City of Hope Medical Center (1) H. Lee Moffitt Cancer Center and Research Institute (1)
Disease Areas
Myelodysplastic Syndromes (MDS) (2) Leukemia (1) Acute Myeloid Leukemia (AML) (1) Acute Lymphoblastic Leukemia (ALL) (1) Myelofibrosis (1)
Get alerts when Itacitinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free